Post
Rouge is iron oxide contamination that deposits on the internal surfaces of stainless steel systems, particularly in pharmaceutical, biotech, and high-purity processing environments that handle water or steam at elevated temperatures. It appears as a reddish-brown, orange, or dark deposit on tubing, vessel walls, and fittings. Derouging is the chemical process that removes it.
Left untreated, rouge signals that the passive chromium oxide layer protecting the stainless steel has been compromised. In regulated environments, the visible deposit is evidence of a deeper compliance problem.
Stainless steel resists corrosion because of a thin, stable chromium oxide layer on its surface. When that layer degrades, iron in the steel oxidizes. The resulting iron oxide deposits are what we call rouge.
The most common triggers are heat and water. WFI loops, purified water systems, and steam-in-place systems create the thermal and chemical conditions where rouging accelerates. Operating temperatures above 65°C significantly increase the rate of iron oxide formation. Systems that cycle between high and low temperatures, or that see periods of stagnant water, are particularly susceptible.
Fabrication is another source. Welding, grinding, and mechanical work can embed free iron in the stainless steel surface or damage the passive layer locally. If the system isn’t passivated after construction or repair, those areas become nucleation points for rouge.
ASME BPE 2026 classifies rouge into three categories based on origin and composition. Knowing which class is present affects how the derouging treatment is designed.
Class I rouge is red or orange-brown and forms in systems that process water at elevated temperatures, including WFI loops and hot purified water systems. It’s composed primarily of hematite (Fe2O3) and tends to be loosely adherent, which means it can migrate through the system and contaminate downstream components. Class I is the most commonly encountered type in pharmaceutical manufacturing.
Class II rouge is dark brown or black and forms in steam environments. It’s composed primarily of magnetite (Fe3O4) and is more tightly adherent than Class I. SIP (steam-in-place) cycles, autoclaves, and steam distribution systems are typical environments. Class II doesn’t migrate as readily, but its presence indicates sustained thermal stress on the passive layer.
Class III rouge is typically black or dark gray and is associated with more advanced corrosion and degradation of the stainless-steel surface. It is generally composed of iron oxides, including magnetite (Fe₂O₄), and is more tightly adherent than Class I and Class II rouge. Class III rouge may develop in systems exposed to severe or prolonged operating conditions and is typically more difficult to remove. Chemical derouging is generally required for removal, followed by passivation to restore the protective passive oxide layer.
For pharmaceutical and biotech facilities, rouge is a contamination and compliance concern. A system showing Class I rouge has iron oxide particles that can shed into the product stream. In bioprocessing and pharmaceutical water systems, that’s a direct contamination risk.
From a compliance standpoint, a rouged system raises questions during validation and audit. A visible iron oxide deposit is evidence that the passive layer has degraded. GMP guidelines require that processing systems remain clean, controlled, and documented. Rouging is a deviation from that standard.
There’s also a corrosion risk. Rouge is a symptom that the passive chromium oxide layer is under stress. If the rouging isn’t addressed, the underlying stainless steel is more susceptible to pitting, crevice corrosion, and stress corrosion cracking over time, particularly in chloride-containing or acidic process environments.
Derouging uses a controlled acid treatment to dissolve the iron oxide deposits from the internal surfaces of the system. The chemistry targets the rouge without attacking the base stainless steel.
BCS uses our proprietary BIOPASS® chemical formulations for derouging. These are biodegradable and non-flammable, which matters for on-site work in pharmaceutical facilities where chemical safety requirements are strict. We select the formulation and concentration based on the class and severity of the rouging and the metallurgy of the system.
The process follows a defined sequence: pre-inspection, chemical treatment, neutralization, rinse, and post-inspection. BCS performs bore-scope inspection before and after treatment to document the condition of the system and confirm the rouge has been removed. Every project includes a validation report, before-and-after inspection documentation, and a Certificate of Compliance.
Derouging is almost always followed by passivation. Removing rouge dissolves the oxide deposits, but the treatment chemistry also affects the chromium oxide passive layer. Passivation per ASTM A967 or ASME BPE 2026 immediately after derouging restores the passive layer and leaves the system in a verified, corrosion-resistant state. Skipping the passivation step after derouging leaves the system vulnerable to re-rouging at an accelerated rate.
BCS performs both treatments in sequence and provides a single compliance package covering the full scope of work.
The most straightforward sign is visual: discoloration inside tubing, vessels, or fittings that ranges from light orange to dark brown or black. Bore-scope inspection makes it possible to detect and classify rouge in systems that aren’t accessible by direct visual inspection.
Other indicators include:
Rouge can also be found incidentally during scheduled maintenance or after a system modification. Any time a pharmaceutical or biotech system is opened for repair, the interior surfaces should be inspected for rouging before being returned to service.
Derouging removes existing rouge, but it doesn’t eliminate the underlying conditions that caused it. Without changes to how the system operates or is maintained, rouge can return within months of treatment.
The most effective steps for slowing re-rouging:
BCS can review your current maintenance program and identify where the schedule or procedure may be contributing to recurring rouge.
BCS has been performing derouging on pharmaceutical, biotech, and high-purity process systems since 1996. We work on-site at your facility or process the components at our workshop in Oakville, Ontario, operating under our ISO-certified Quality Management System. For critical systems that can’t be taken offline for extended periods, we coordinate with your maintenance and validation teams to schedule treatment with minimal disruption.
All derouging projects include full compliance documentation: bore-scope inspection reports, a comprehensive job report (which includes free iron testing results where applicable), and a Certificate of Compliance. If passivation follows derouging, both are covered in a single integrated package.
Rouge has a characteristic appearance: reddish-brown (Class I from water systems), dark brown or black with tighter adherence (Class II from steam systems), or black to dark gray with more advanced surface degradation (Class III from prolonged or severe operating conditions). Bore-scope inspection is the most reliable method for confirming rouge and determining its classification. If you’re unsure, BCS can perform a pre-treatment inspection and assess the system before recommending a treatment plan.
There’s no single interval that fits all systems. Frequency depends on operating temperature, the water quality of your process stream, system age, and your facility’s maintenance schedule. Many pharmaceutical facilities schedule derouging as part of a Preventive Maintenance Program, with inspections triggered by operating hours, visual observations, or water quality data. BCS can review your system’s history and usage profile to suggest an appropriate maintenance interval.
Yes. Derouging requires internal access to circulate the chemical treatment through the system. For WFI loops and purified water systems, this typically means a planned maintenance window. BCS works with your scheduling team to minimize downtime.
In almost every case, yes. Removing rouge with acid chemistry affects the chromium oxide passive layer. Passivation per ASTM A967 or ASME BPE 2026 immediately after restores the passive layer and prevents rapid re-rouging. BCS performs both in sequence and covers both in a single compliance package.
Passivation removes free iron from the stainless steel surface and restores the chromium oxide passive layer. It doesn’t remove rouge that’s already formed. Derouging uses a different chemistry specifically designed to dissolve iron oxide deposits. For systems with active rouge, derouging comes first; passivation follows to protect the treated surface.
Yes. BCS offers on-site derouging across North America for WFI systems, bioreactors, purified water loops, process piping, and vessels. We also perform in-house treatment at our workshop in Oakville for components that can be removed and transported.
If your system shows signs of rouge or hasn’t been inspected in over 12 months, BCS can perform a bore-scope assessment and recommend a treatment plan. We provide on-site service across North America with full compliance documentation on every project.
Contact BCS to schedule a derouging assessment.
Related reading: ASTM A967 vs. ASTM A380 passivation standards · Passivation vs. pickling stainless steel
You will find the most recent articles..
